Gene therapy candidate for amyotrophic lateral sclerosis (ALS) demonstrates bioactivities in a murine model of the disease

NEW YORK, March 13, 2023.  ANEW MEDICAL, INC. ( " ANEW ' ' or the " Company " ), a medical product development company, announced results presented at the European Society of Cell and Gene Therapy (ESCGT) from preclinical in vivo studies of its lead...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials